Real-time enrollment status for this phenylketonuria (pku) and hyperphenylalaninemia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:55 PM UTC
| NCT Number | NCT07551921 |
| Recruiting Status | Recruiting |
| Condition | Phenylketonuria (PKU) and Hyperphenylalaninemia |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Aptatek BioSciences, Inc |
| Last Updated on CT.gov | August 25, 2026 (Aug 25, 2026) |
As of October 12, 2026: Clinical trial NCT07551921 is currently recruiting participants. This clinical trial study for phenylketonuria (pku) and hyperphenylalaninemia is actively seeking new participants at 2 locations across the United States. The study is sponsored by Aptatek BioSciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07551921 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07551921 was last updated Aug 25, 2026 (August 25, 2026). HelloStudys verifies this status automatically.